Litigation Details for SUPERNUS PHARMACEUTICALS, INC. v. AJANTA PHARMA LIMITED (D.N.J. 2021)
✉ Email this page to a colleague
SUPERNUS PHARMACEUTICALS, INC. v. AJANTA PHARMA LIMITED (D.N.J. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-03-26 |
| Court | District Court, D. New Jersey | Date Terminated | 2024-02-22 |
| Cause | 35:271 Patent Infringement | Assigned To | Georgette Castner |
| Jury Demand | None | Referred To | Justin T. Quinn |
| Parties | AJANTA PHARMA LIMITED | ||
| Patents | 10,314,790; 8,298,576; 8,298,580; 8,663,683; 8,877,248; 8,889,191; 8,992,989; 9,549,940; 9,555,004; 9,622,983 | ||
| Attorneys | WILLIAM C. BATON | ||
| Firms | Eric I. Abraham | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUPERNUS PHARMACEUTICALS, INC. v. AJANTA PHARMA LIMITED
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for SUPERNUS PHARMACEUTICALS, INC. v. AJANTA PHARMA LIMITED (D.N.J. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-03-26 | 1 | Complaint | : 2 patent”), 9,555,004 (“the ’004 patent”), 9,622,983 (“the ’983 patent”), and 10,314,790 (“the ’… United States Patent Nos. 8,298,576 (“the ’576 patent”), 8,298,580 (“the ’580 patent”), 8,663,683 (“…(“the ’683 patent”), 8,877,248 (“the ’248 patent”), 8,889,191 (“the ’191 patent”), 8,992,989 (“the ’989… the ’576 patent, claims 2-16 and 18-31 of the ’580 patent, claims 2-24 of the ’683 patent, claims 2-… ’248 patent, claims 2-24 of the ’191 patent, claims 2-13, 16-17, and 19-20 of the ’989 patent, claims | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
